EARLY-STAGE HER2+ BREAST CANCER

Clinical trials for EARLY-STAGE HER2+ BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new EARLY-STAGE HER2+ BREAST CANCER trials appear

Sign up with your email to follow new studies for EARLY-STAGE HER2+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Travel time may impact breast cancer treatment completion

Knowledge-focused Recruiting now

This study looks at 100 people with early-stage HER2-positive breast cancer in Serbia to see if traveling farther for treatment affects how well they stick to their medication plan. Researchers will compare those who have to travel more with those who don't. The goal is to unders…

Matched conditions: EARLY-STAGE HER2+ BREAST CANCER

Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused

Last updated May 17, 2026 01:59 UTC

EARLY-STAGE HER2+ BREAST CANCER

Get alerted when new EARLY-STAGE HER2+ BREAST CANCER trials appear

Travel time may impact breast cancer treatment completion